The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...

In a report released yesterday, Neil Kalton from Wells Fargo maintained a Hold rating on Exelon (EXC – Research Report), with a price target of ...

Exelon's regulated utilities support our growth outlook at the midpoint of the company's 5%-7% annual earnings growth guidance through 2028. We estimate the company will invest roughly $38 billion ...

Shares of Exelon Corp. EXC rallied 1.25% to $42.89 Wednesday, on what proved to be an all-around rough trading session for ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

The updated capital expenditure plan for 2025-2028 includes $38 billion, with $9.1 billion allocated for 2025. Transmission investments remain a priority, driven by structural trends such as ...

Major U.S. electric utility Exelon increased its four-year capital investment plan by 10% to $38 billion, with the bulk of ...

The teen years are no joke. Many parents of 15-year-old kids are constantly hearing from their teens how their friends get to do so much more than they are allowed to do and how they are being ...

Although MG hasn’t revealed exact specifications yet, going by the dimensions of the international-spec D90 Max, the Majestor could measure 5,046mm in length, 2,016mm in width and 1,876mm in ...

Barclays analyst Nicholas Campanella maintained a Buy rating on Exelon (EXC – Research Report) today and set a price target of $42.00. The company’s shares closed yesterday at $40.44.

Rugby league personality Mark ‘MG’ Geyer is joining Sydney’s 2GB and Nine Radio on a three-year deal. The NSW and Australian representative and NRL premiership winner will be heard daily on 2GB’s new ...